SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-22-000075
Filing Date
2022-08-09
Accepted
2022-08-09 16:02:55
Documents
57
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20220630.htm   iXBRL 10-Q 1050430
2 EX-3.1 exhibit31_amendedandrestat.htm EX-3.1 171625
3 EX-31.1 exhibit311_20220630.htm EX-31.1 15478
4 EX-31.2 exhibit312_20220630.htm EX-31.2 15234
5 EX-32.1 exhibit321_20220630.htm EX-32.1 4344
6 EX-32.2 exhibit322_20220630.htm EX-32.2 4332
12 dare-20220630_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-22-000075.txt   5651605

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20220630.xsd EX-101.SCH 44917
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20220630_cal.xml EX-101.CAL 37735
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20220630_def.xml EX-101.DEF 216733
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20220630_lab.xml EX-101.LAB 503819
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20220630_pre.xml EX-101.PRE 314741
51 EXTRACTED XBRL INSTANCE DOCUMENT dare-20220630_htm.xml XML 672859
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 221148152
SIC: 2834 Pharmaceutical Preparations